Heron Therapeutics Inc HRTX:NASDAQ

Last Price$19.29NASDAQ Previous Close - Last Trade as of 4:15PM ET 6/05/20

Today's Change+0.86(4.67%)
Bid (Size)$19.16 (23)
Ask (Size)$19.75 (1)
Day Low / High$18.56 - 19.51
Volume882.3 K

Heron Therapeutics Down 4% After FDA Extends Review Period for HTX-011 Non-Opioid Pain Medication

1:57PM ET 2/20/2020 MT Newswires
Heron Therapeutics (HRTX) dropped 4% after the company said the US Food and Drug Administration extended the review period for the company's HTX-011 drug candidate by up to three additional months, or until June 26.

The company did not say why the agency was delaying a decision for the non-opioid pain medication although it said FDA officials were indicating they could complete their work in less time.

Heron also said the FDA has completed its re-inspection of the company's contract manufacturer and is now recommending approval of the site. The agency previously had raised questions about chemistry, manufacturing and controls at the facility in an April 2019 complete response letter.

Price: 20.65, Change: -1.01, Percent Change: -4.66